Skip to main content
. 2021 Jun 4;60(11):1407–1421. doi: 10.1007/s40262-021-01024-y

Fig. 1.

Fig. 1

Flow of patients through the SOCRATES-REDUCED study and eligible samples for vericiguat pharmacokinetic (PK) and PK/pharmacodynamic (PD) analyses. HR heart rate, LLOQ lower limit of quantification, N/A not applicable, SBP systolic blood pressure